Aripiprazole (ABILIFY MAINTENA®): A Review of Its Use as Maintenance Treatment for Adult Patients with Schizophrenia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aripiprazole (ABILIFY MAINTENA®): A Review of Its Use as Maintenance Treatment for Adult Patients with Schizophrenia
Authors
Keywords
Schizophrenia, Antipsychotic Drug, Aripiprazole, Tardive Dyskinesia, Paliperidone
Journal
DRUGS
Volume 74, Issue 10, Pages 1097-1110
Publisher
Springer Nature
Online
2014-06-26
DOI
10.1007/s40265-014-0231-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study
- (2014) W. Wolfgang Fleischhacker et al. BRITISH JOURNAL OF PSYCHIATRY
- Cost-effectiveness of aripiprazole once-monthly compared with paliperidone palmitate once-monthly injectable for the treatment of schizophrenia in the United States
- (2014) Leslie Citrome et al. JOURNAL OF MEDICAL ECONOMICS
- Long-Acting Injectable Formulations of New-Generation Antipsychotics: A Review from a Clinical Perspective
- (2013) Anna-Sophia Rauch et al. CNS DRUGS
- “Meta-guidelines” for the management of patients with schizophrenia
- (2013) Stephen M. Stahl et al. CNS SPECTRUMS
- Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole
- (2013) Steven G. Potkin et al. CURRENT MEDICAL RESEARCH AND OPINION
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study
- (2013) Suresh Mallikaarjun et al. SCHIZOPHRENIA RESEARCH
- Impact on healthcare resource usage and costs among Medicaid-insured schizophrenia patients after initiation of treatment with long-acting injectable antipsychotics
- (2013) Rimal Bera et al. JOURNAL OF MEDICAL ECONOMICS
- Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia
- (2013) John M. Kane et al. JOURNAL OF MEDICAL ECONOMICS
- The Cost Effectiveness of Long-Acting/Extended-Release Antipsychotics for the Treatment of Schizophrenia
- (2013) Evanthia Achilla et al. Applied Health Economics and Health Policy
- Aripiprazole
- (2012) Jamie D. Croxtall CNS DRUGS
- New insights into the mechanism of drug-induced dyskinesia
- (2012) Anton J. M. Loonen et al. CNS SPECTRUMS
- Efficacy and safety of second-generation long-acting injections in schizophrenia
- (2012) Paolo Fusar-Poli et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia
- (2012) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
- (2011) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Aripiprazole
- (2011) Sohita Dhillon DRUGS
- The cost of relapse and the predictors of relapse in the treatment of schizophrenia
- (2010) Haya Ascher-Svanum et al. BMC Psychiatry
- Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia
- (2010) Diego Novick et al. PSYCHIATRY RESEARCH
- Second-Generation Antipsychotic Drugs and Extrapyramidal Side Effects: A Systematic Review and Meta-analysis of Head-to-Head Comparisons
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA BULLETIN
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
- (2010) Rajiv Tandon et al. SCHIZOPHRENIA RESEARCH
- Schizophrenia
- (2009) Jim van Os et al. LANCET
- The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
- (2009) R. W. Buchanan et al. SCHIZOPHRENIA BULLETIN
- Schizophrenia, “just the facts” 4. Clinical features and conceptualization
- (2009) Rajiv Tandon et al. SCHIZOPHRENIA RESEARCH
- Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
- (2008) J. McGrath et al. EPIDEMIOLOGIC REVIEWS
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
- Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects
- (2008) Katrin M. Kirschbaum et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started